Poteligeo

Mogamulizumab-kpkc · Targeted Monoclonal Antibody

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Targeted treatment of solid tumors and hematologic malignancies.

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Infusion reactions, fatigue, rash, hematologic alterations, musculoskeletal pain.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.